中风与神经疾病杂志2024,Vol.41Issue(6) :507-510.DOI:10.19845/j.cnki.zfysjjbzz.2024.0096

新型抗癫痫发作药物布瓦西坦作用机制及临床研究进展

Advances in the mechanism of action and clinical studies of the novel antiepileptic drug brivaracetam

万丽君 刘学伍
中风与神经疾病杂志2024,Vol.41Issue(6) :507-510.DOI:10.19845/j.cnki.zfysjjbzz.2024.0096

新型抗癫痫发作药物布瓦西坦作用机制及临床研究进展

Advances in the mechanism of action and clinical studies of the novel antiepileptic drug brivaracetam

万丽君 1刘学伍1
扫码查看

作者信息

  • 1. 山东第一医科大学附属省立医院神经内科,山东 济南 250021
  • 折叠

摘要

癫痫是神经系统常见疾病之一,是以脑神经元异常放电引起反复痫性发作为特征.布瓦西坦是第三代抗癫痫药物之一左乙拉西坦的类似物,通过与突触囊泡蛋白2A结合而起作用.本文就癫痫的概述、布瓦西坦在癫痫中的作用机制、药代动力学特征、临床疗效、安全性及不良反应等方面进行综述,以期为癫痫治疗提供更好的药物选择.

Abstract

Epilepsy is one of the common diseases of the nervous system,which is characterized by repeated epilep-tic seizures caused by abnormal discharge of brain neurons.Brivaracetam is an analogue of the third-generation antiepilep-tic drug levetiracetam and exerts a therapeutic effect by binding to synaptic vesicular protein 2A.This article reviews the disease of epilepsy and the mechanism of action,pharmacokinetic characteristics,clinical efficacy,safety,and adverse reactions of brivaracetam in epilepsy,in order to provide a better choice of drugs for the treatment of epilepsy.

关键词

癫痫/布瓦西坦/抗癫痫药物/突触囊泡蛋白

Key words

Epilepsy/Brivaracetam/Antiepileptic drugs/Synaptic vesicular protein

引用本文复制引用

出版年

2024
中风与神经疾病杂志
吉林大学

中风与神经疾病杂志

CSTPCD
影响因子:0.754
ISSN:1003-2754
参考文献量33
段落导航相关论文